|
Jul 21
|
Sanofi (SNY) Expands Rare Disease Reach With $9.5B Blueprint Deal
|
|
Jul 21
|
Sanofi concludes Blueprint Medicines acquisition
|
|
Jul 18
|
Press Release: Sanofi completes acquisition of Blueprint Medicines
|
|
Jul 17
|
Press Release: Sanofi announces extension of Blueprint tender offer
|
|
Jul 14
|
High Growth Tech Stocks To Watch In The US July 2025
|
|
Jul 14
|
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now.
|
|
Jun 20
|
Exploring 3 High Growth Tech Stocks in the US Market
|
|
Jun 19
|
Exploring Three High Growth Tech Stocks In The US Market
|
|
Jun 17
|
Exploring High Growth Tech Opportunities in US Markets
|
|
May 3
|
Blueprint Medicines First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
|
|
May 2
|
Blueprint Medicines Stock Up Despite Lower-Than-Expected Q1 Earnings
|
|
May 2
|
Blueprint Medicines Corp (BPMC) Q1 2025 Earnings Call Highlights: Strong AYVAKIT Revenue Growth ...
|
|
May 2
|
Q1 2025 Blueprint Medicines Corp Earnings Call
|
|
May 1
|
Blueprint Medicines (BPMC) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 1
|
Blueprint Medicines: Q1 Earnings Snapshot
|
|
May 1
|
Blueprint Medicines Reports First Quarter 2025 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
|
|
Feb 15
|
Blueprint Medicines Full Year 2024 Earnings: EPS Beats Expectations
|
|
Feb 14
|
BPMC Q4 Earnings and Sales Miss Estimates, Shares Decline
|
|
Feb 14
|
Blueprint Medicines Corp (BPMC) Q4 2024 Earnings Call Highlights: Record Growth and Strategic ...
|
|
Feb 14
|
Q4 2024 Blueprint Medicines Corp Earnings Call
|